Pfizer Europe MA EEIG - arama sonuçları

Avrupa Birliği - Bulgarca - EMA (European Medicines Agency)

apexxnar

pfizer europe ma eeig - pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 8, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 10a, pneumococcal polysaccharide serotype 11a, pneumococcal polysaccharide serotype 12f, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 15b, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal polysaccharide serotype 19f, pneumococcal polysaccharide serotype 22f, pneumococcal polysaccharide serotype 23f, pneumococcal polysaccharide serotype 33f - Пневмококови инфекции - Ваксини - active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. Вижте раздели 4. 4 и 5. 1 за информация относно защитата срещу специфични пневмококови серотипове. apexxnar should be used in accordance with official recommendations. .

Avrupa Birliği - Bulgarca - EMA (European Medicines Agency)

abrysvo

pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - Инфекции на респираторния синцитиален вирус - Ваксини - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. Вижте раздели 4. 2 и 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. Използването на тази ваксина трябва да бъде приложена в съответствие с официалните препоръки.

Avrupa Birliği - Bulgarca - EMA (European Medicines Agency)

benefix

pfizer europe ma eeig - nonacog Алфа - Хемофилия Б - Антихеморагични - Лечение и профилактика на кървене при пациенти с хемофилия В (вродена дефицит на фактор ix).

Avrupa Birliği - Bulgarca - EMA (European Medicines Agency)

raylumis

pfizer europe ma eeig - tanezumab - osteoarthritis; pain - Аналгетици - treatment of moderate to severe chronic pain associated with osteoarthritis (oa) of the hip or knee in adult patients for whom treatment with non-steroidal anti-inflammatory drugs (nsaids) and/or any opioid is ineffective, not tolerated or inappropriate.